Detalhe da pesquisa
1.
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature
; 612(7941): 778-786, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517593
2.
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 187: 80-84, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735143
3.
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes.
Gynecol Oncol
; 182: 32-38, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246044
4.
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Gynecol Oncol
; 186: 104-109, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640773
5.
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
Gynecol Oncol
; 182: 141-147, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262237
6.
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Gynecol Oncol
; 180: 35-43, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041901
7.
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Gynecol Oncol
; 183: 126-132, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493020
8.
Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go?
Int J Gynecol Cancer
; 34(3): 379-385, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438179
9.
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
Int J Gynecol Cancer
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514101
10.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer
; 34(4): 594-601, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296517
11.
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.
Proc Natl Acad Sci U S A
; 118(25)2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161278
12.
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
Cancer
; 129(13): 2004-2012, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951509
13.
Cross-sectional survey of surgical practices among gynecologic oncologists in the United States.
Gynecol Oncol
; 172: 36-40, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933401
14.
A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma.
Gynecol Oncol
; 176: 90-97, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478617
15.
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 169: 118-124, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565685
16.
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 179: 169-179, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992548
17.
Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
Gynecol Oncol
; 169: 85-90, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521353
18.
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial.
Gynecol Oncol
; 171: 23-30, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804618
19.
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications.
Gynecol Oncol
; 175: 163-168, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390597
20.
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 176: 69-75, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454565